STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

LUNG CANCER RESEARCH FOUNDATION: Form 990, tax year 2022

View the entire original 990 at ProPublica ↗

Organization
LUNG CANCER RESEARCH FOUNDATION (EIN 14-1935776)
Tax period
2022-01-01 to 2022-12-31
Filed
2023-10-25
IRS object ID
202342989349300504
Schema version
2022v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-10-25T06:11:58-05:00ReturnTs
Tax Period End2022-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN872525370PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CITRIN COOPERMAN ADVISORS LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line150 ROCKEFELLER PLAZAAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10020ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2022-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN141935776EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1LUNG CANCER RESEARCH FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlLUNGBusinessNameControlTxt
Phone2125881580PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1501 7TH AVENUE 230AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10018ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonAUBREY RHODESPersonNm
Person TitleEXECUTIVE DIRECTORPersonTitleTxt
Phone2125881580PhoneNum
Signature2023-10-24SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstAUBREYPersonFirstNm
Person LastRHODESPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN
FieldValueIRS element (for citing)
IRS Responsible Prty Info Curr0IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonAMANDA ADAMSPreparerPersonNm
PTINP00748038PTIN
Phone2126971000PhoneNum
Preparation2023-10-23PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2022TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Address ChangeYes (X)AddressChangeInd
Principal OfficerAUBREY RHODESPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1501 7TH AVENUE 230AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10018ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$7,074,135GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.LCRF.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2005FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionTHE MISSION OF THE LUNG CANCER RESEARCH FOUNDATION IS TO IMPROVE LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER.ActivityOrMissionDesc
Voting Members Governing Body14VotingMembersGoverningBodyCnt
Voting Members Independent14VotingMembersIndependentCnt
Total Employee22TotalEmployeeCnt
Total Volunteers10TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$6,344,359PYContributionsGrantsAmt
CY Contributions Grants$7,013,446CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$1,402PYInvestmentIncomeAmt
CY Investment Income$28,829CYInvestmentIncomeAmt
PY Other Revenue-$191,509PYOtherRevenueAmt
CY Other Revenue-$438,719CYOtherRevenueAmt
PY Total Revenue$6,154,252PYTotalRevenueAmt
CY Total Revenue$6,603,556CYTotalRevenueAmt
PY Grants And Similar Paid$1,799,919PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$3,052,308CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$2,054,786PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$2,157,339CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$73,650PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$127,467CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$694,704CYTotalFundraisingExpenseAmt
PY Other Expenses$1,412,133PYOtherExpensesAmt
CY Other Expenses$1,219,816CYOtherExpensesAmt
PY Total Expenses$5,340,488PYTotalExpensesAmt
CY Total Expenses$6,556,930CYTotalExpensesAmt
PY Revenues Less Expenses$813,764PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$46,626CYRevenuesLessExpensesAmt
Total Assets BOY$5,738,095TotalAssetsBOYAmt
Total Assets EOY$5,557,342TotalAssetsEOYAmt
Total Liabilities BOY$2,230,097TotalLiabilitiesBOYAmt
Total Liabilities EOY$1,973,122TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$3,507,998NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$3,584,220NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE MISSION OF THE LUNG CANCER RESEARCH FOUNDATION IS TO IMPROVE LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$3,886,365ExpenseAmt
Grant$3,052,308GrantAmt
DescRESEARCH: EACH YEAR, LCRF AWARDS RESEARCH GRANTS TO RECIPIENTS AROUND THE WORLD THAT DEMONSTRATE PROMISE AND INGENUITY IN THEIR WORK. INVESTIGATORS ARE SELECTED FROM HUNDREDS OF APPLICANTS AND REPRESENT SOME OF THE BRIGHTEST MINDS COMMITTED TO IMPROVING OUTCOMES FOR LUNG CANCER PATIENTS. THEY COME FROM VARIOUS CAREER PATHS INCLUDING SCIENTISTS, PHYSICIANS, STUDENTS, AND FELLOWS, AND WORKING ON A VARIETY OF INNOVATIVE RESEARCH PROJECTS RELATED TO LUNG CANCER.SEE SCHEDULE O FOR ADDITIONAL INFORMATION.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,697,231ExpenseAmt
DescPATIENT EDUCATION & OUTREACH: WE PROVIDE UP-TO-DATE AND CREDIBLE SOURCES OF INFORMATION ON DIAGNOSIS, TREATMENT, AND WHAT TO EXPECT FROM TREATMENT THROUGH OUR FREE EDUCATIONAL MATERIALS. WE ALSO HAVE TOOLS TO HELP YOU FACILITATE DISCUSSIONS WITH YOUR HEALTHCARE TEAM SO YOU CAN PLAY AN ACTIVE ROLE IN TREATMENT DECISIONS. OUR MATERIALS ARE AVAILABLE IN BOTH DIGITAL DOWNLOAD AND PRINT FORMAT.SEE SCHEDULE O FOR ADDITIONAL INFORMATION.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$5,583,596TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional FundraisingYes (1)ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document23IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee22EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members14GoverningBodyVotingMembersCnt
Independent Voting Member14IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonTONEL RODGERSPersonNm
Phone2125881580PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1501 7TH AVE SUITE 230AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10018ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (20 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
REINA HONTS
CHAIRMAN5.00Yes (X)Yes (X)$0$0$0
BRENDON M STILES MD
VICE CHAIR3.00Yes (X)Yes (X)$0$0$0
MARY ANN TIGHE
VICE CHAIR3.00Yes (X)Yes (X)$0$0$0
AARON M TIGHE
TREASURER3.00Yes (X)Yes (X)$0$0$0
KATERINA POLITI PHD
DIRECTOR1.00Yes (X)$0$0$0
JOAN H SCHILLER MD
DIRECTOR1.00Yes (X)$0$0$0
RAY E CHALME
DIRECTOR1.00Yes (X)$0$0$0
BRUCE DUNBAR
DIRECTOR1.00Yes (X)$0$0$0
PETER FRY
DIRECTOR1.00Yes (X)$0$0$0
JILL FURMAN
DIRECTOR1.00Yes (X)$0$0$0
SCOTT MORRIS
DIRECTOR1.00Yes (X)$0$0$0
MATTHEW CIPRIANI
DIRECTOR1.00Yes (X)$0$0$0
ROSE ANN WEINSTEIN
DIRECTOR1.00Yes (X)$0$0$0
COLLEN CONNOR-ZIEGLER
DIRECTOR1.00Yes (X)$0$0$0
DENNIS CHILLEMI
EXECUTIVE DIRECTOR40.00Yes (X)$240,000$0$8,999
TONEL RODGERS
DIRECTOR, FINANCE & ADMINISTRATION40.00Yes (X)$124,042$0$20,027
AUBREY RHODES
SENIOR VP, STRATEGY40.00$166,072$0$18,481Yes (X)
SHEILA SULLIVAN
SR. DIRECTOR, MARKETING & COMMUNICATIONS40.00$132,600$0$34,641Yes (X)
STACEY BOWERS
SR. DIRECTOR, COMMUNITY ENGAGEMENT40.00$119,615$0$39,919Yes (X)
SAM ROGERS
VICE PRESIDENT, DEVELOPMENT40.00$115,769$0$29,007Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$898,098TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$151,074TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K6IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (2 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
CONRAD & ASSOCIATES LLC
11105 TARA RDPOTOMACMD20854HISPANIC LUNG CANCER PROGRAM PARTNER$200,000
PROSKAUER ROSE LLP
ELEVEN TIME SQUARENEW YORKNY10036LEGAL$144,078
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K2CntrctRcvdGreaterThan100KCnt
Fundraising$2,088,863FundraisingAmt
All Other Contributions$4,924,583AllOtherContributionsAmt
Total Contributions$7,013,446TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$28,829TotalRevenueColumnAmt
Exclusion$28,829ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$31,860FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$2,088,863ContriRptFundraisingEventAmt
Fundraising Direct Expenses$470,579FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$438,719TotalRevenueColumnAmt
Exclusion-$438,719ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$6,603,556TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion-$409,890ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$3,052,308TotalAmt
Program Services$3,052,308ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$393,068TotalAmt
Program Services$258,763ProgramServicesAmt
Management And General$93,008ManagementAndGeneralAmt
Fundraising$41,297FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,317,423TotalAmt
Program Services$943,534ProgramServicesAmt
Management And General$88,780ManagementAndGeneralAmt
Fundraising$285,109FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$45,398TotalAmt
Program Services$32,643ProgramServicesAmt
Management And General$2,902ManagementAndGeneralAmt
Fundraising$9,853FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$270,383TotalAmt
Program Services$193,703ProgramServicesAmt
Management And General$24,966ManagementAndGeneralAmt
Fundraising$51,714FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$131,067TotalAmt
Program Services$90,648ProgramServicesAmt
Management And General$14,180ManagementAndGeneralAmt
Fundraising$26,239FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$153,026TotalAmt
Program Services$151,795ProgramServicesAmt
Management And General$432ManagementAndGeneralAmt
Fundraising$799FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$41,941TotalAmt
Program Services$22,395ProgramServicesAmt
Management And General$9,468ManagementAndGeneralAmt
Fundraising$10,078FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$127,467TotalAmt
Fundraising$127,467FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$228,053TotalAmt
Program Services$206,733ProgramServicesAmt
Management And General$8,330ManagementAndGeneralAmt
Fundraising$12,990FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$259,028TotalAmt
Program Services$259,028ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$75,721TotalAmt
Program Services$49,616ProgramServicesAmt
Management And General$3,532ManagementAndGeneralAmt
Fundraising$22,573FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$247,834TotalAmt
Program Services$174,274ProgramServicesAmt
Management And General$21,251ManagementAndGeneralAmt
Fundraising$52,309FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$75,939TotalAmt
Program Services$53,666ProgramServicesAmt
Management And General$6,434ManagementAndGeneralAmt
Fundraising$15,839FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$32,113TotalAmt
Program Services$30,507ProgramServicesAmt
Management And General$1,606ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$3,178TotalAmt
Program Services$3,043ProgramServicesAmt
Management And General$135ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$22,415TotalAmt
Program Services$15,762ProgramServicesAmt
Management And General$1,922ManagementAndGeneralAmt
Fundraising$4,731FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$19,635TotalAmt
Program Services$13,807ProgramServicesAmt
Management And General$1,684ManagementAndGeneralAmt
Fundraising$4,144FundraisingAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtFundraisingFundraisingAmt
PROGRAM MATERIALS$31,300$31,300
BAD DEBTS$16,952$16,952
STATE FILING FEES$12,610$12,610

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$71TotalAmt
Program Services$71ProgramServicesAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$6,556,930TotalAmt
Program Services$5,583,596ProgramServicesAmt
Management And General$278,630ManagementAndGeneralAmt
Fundraising$694,704FundraisingAmt

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$32,060TotalAmt
Program Services$12,824ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$19,236FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$199,450BOYAmt
EOY$357,492EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$4,773,589BOYAmt
EOY$3,426,938EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$595,226BOYAmt
EOY$1,506,082EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$143,915BOYAmt
EOY$121,571EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$55,000LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$55,000LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$22,415BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$3,500BOYAmt
EOY$145,259EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$5,738,095BOYAmt
EOY$5,557,342EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$341,683BOYAmt
EOY$242,499EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$1,527,047BOYAmt
EOY$1,567,602EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$361,367BOYAmt
EOY$32,735EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$130,286EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,230,097BOYAmt
EOY$1,973,122EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$2,209,943BOYAmt
EOY$2,427,004EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$1,298,055BOYAmt
EOY$1,157,216EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$3,507,998BOYAmt
EOY$3,584,220EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,738,095BOYAmt
EOY$5,557,342EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$46,626ReconcilationRevenueExpnssAmt
Other Changes In Net Assets$29,596OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,296,669CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,916,763CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,465,693CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,344,359CurrentTaxYearMinus1YearAmt
Current Tax Year$7,013,446CurrentTaxYearAmt
Total$31,036,930TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,296,669CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,916,763CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,465,693CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,344,359CurrentTaxYearMinus1YearAmt
Current Tax Year$7,013,446CurrentTaxYearAmt
Total$31,036,930TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$4,634,602SubstantialContributorsTotAmt
Public Support Total170$26,402,328PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$7,994CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,178CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,357CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,402CurrentTaxYearMinus1YearAmt
Current Tax Year$28,829CurrentTaxYearAmt
Total$42,760TotalAmt
FieldValueIRS element (for citing)
Total Support$31,079,690TotalSupportAmt
Gross Receipts Rltd Activities$35,115GrossReceiptsRltdActivitiesAmt
Public Support CY1700.84950PublicSupportCY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind
Public Support PY5090.93490PublicSupportPY509Pct
Investment Income PY0.00190InvestmentIncomePYPct

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$55,000OtherCostOrOtherBasisAmt
Depreciation$55,000DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$0TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescOPERATING LEASE LIABILITIESDesc
Amt$130,286Amt
FieldValueIRS element (for citing)
Total Liability$130,286TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$6,493,024TotalRevEtcAuditedFinclStmtAmt
Donated Services And Use Fclts$16,935DonatedServicesAndUseFcltsAmt
Revenue Not Reported$16,935RevenueNotReportedAmt
Revenue Subtotal$6,476,089RevenueSubtotalAmt
Other Revenues Not Included$127,467OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$127,467RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$6,603,556TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$6,416,802TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$16,935DonatedServicesUseFcltsAmt
Expenses Not Reported$16,935ExpensesNotReportedAmt
Expenses Subtotal$6,399,867ExpensesSubtotalAmt
Other Expenses Not Included$157,063OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$157,063ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$6,556,930TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART X, LINE 2:THE FOUNDATION RECOGNIZES AND MEASURES ITS UNRECOGNIZED TAX BENEFITS IN ACCORDANCE WITH FASB ASC 740, INCOME TAXES. UNDER THAT GUIDANCE, THE FOUNDATION ASSESSES THE LIKELIHOOD, BASED ON THEIR TECHNICAL MERIT, THAT TAX POSITIONS WILL BE SUSTAINED UPON EXAMINATION BASED ON THE FACTS, CIRCUMSTANCES AND INFORMATION AVAILABLE AT THE END OF EACH PERIOD. THE MEASUREMENT OF UNRECOGNIZED TAX BENEFITS IS ADJUSTED WHEN NEW INFORMATION IS AVAILABLE, OR WHEN AN EVENT OCCURS THAT REQUIRES A CHANGE. MANAGEMENT HAS EVALUATED THE FOUNDATION'S TAX POSITIONS AND BELIEVES THAT THE FOUNDATION HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE ADJUSTMENTS TO THE FINANCIAL STATEMENTS.
PART XI, LINE 4B - OTHER ADJUSTMENTS:PROFESSIONAL FUNDRAISING FEES NETTED AGAINST REVENUE 127,467.
PART XII, LINE 4B - OTHER ADJUSTMENTS:RETURNED GRANT FUNDS NETTED AGAINST EXPENSE 29,596. PROFESSIONAL FUNDRAISING FEES NETTED AGAINST REVENUE 127,467.

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (1)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdActivityActivityTxtFundraiser Control Of FundsFundraiserControlOfFundsIndGross ReceiptsGrossReceiptsAmtRetained By ContractorRetainedByContractorAmtNet To OrganizationNetToOrganizationAmt
ON THE LOT EVENTS DBA OP3
1150 WEST 48TH STLOS ANGELESCA90037EVENT MGMT AND FUNDRAISING0$682,250$86,000$596,250
SAVE THE DATE INC
429 GREENWICH ST 9ANEW YORKNY10013EVENT MGMT AND FUNDRAISING0$616,200$35,000$581,200
CONNECTEDNONPROFIT INC
1423 EAST 8TH AVEDENVERCO80218EVENT MGMT AND FUNDRAISING0$139,894$6,467$133,427
FieldValueIRS element (for citing)
Total Gross Receipts$1,438,344TotalGrossReceiptsAmt
Total Retained By Contractors$127,467TotalRetainedByContractorsAmt
Total Net To Organization$1,310,877TotalNetToOrganizationAmt
Licensed StatesNYLicensedStatesCd
Licensed StatesALLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesOKLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1ELLIOT'S LEGACYEvent1Nm
Gross Receipts Event1$541,709GrossReceiptsEvent1Amt
Charitable Contri Event1$525,149CharitableContriEvent1Amt
Gross Revenue Event1$16,560GrossRevenueEvent1Amt
Rent Facility Costs Event1$33,458RentFacilityCostsEvent1Amt
Food And Beverage Event1$24,779FoodAndBeverageEvent1Amt
Entertainment Event1$5,680EntertainmentEvent1Amt
Other Direct Expenses Event1$58,627OtherDirectExpensesEvent1Amt
Event2GALAEvent2Nm
Gross Receipts Event2$616,200GrossReceiptsEvent2Amt
Charitable Contri Event2$600,900CharitableContriEvent2Amt
Gross Revenue Event2$15,300GrossRevenueEvent2Amt
Rent Facility Costs Event2$28,014RentFacilityCostsEvent2Amt
Food And Beverage Event2$65,608FoodAndBeverageEvent2Amt
Other Direct Expenses Event2$62,457OtherDirectExpensesEvent2Amt
Other Events Total10OtherEventsTotalCnt
Gross Receipts Other Events$962,814GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$962,814CharitableContriOtherEventsAmt
Oth Direct Expnss Other Events$191,956OthDirectExpnssOtherEventsAmt
Gross Receipts Total$2,120,723GrossReceiptsTotalAmt
Charitable Contributions Tot$2,088,863CharitableContributionsTotAmt
Gross Revenue Total Events$31,860GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$61,472RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$90,387FoodAndBeverageTotalEventsAmt
Entertainment Total Events$5,680EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$313,040OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$470,579DirectExpenseSummaryEventsAmt
Net Income Summary-$438,719NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (19 entries)

Address Line1USAddress/AddressLine1TxtAddress Line2USAddress/AddressLine2TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxt
COLUMBIA UNIVERSITY MEDICAL CENTER
615 WEST 131 ST STREET - MAIL CODE87 49NEW YORKNY10032135598093501(C)(3)$300,000$0RESEARCH
FRED HUTCHINSON CANCER CENTER
PO BOX 19024 MAIL STOP J6-330SEATTLEWA98109911935159501(C)(3)$150,000$0RESEARCH
INDIANA UNIVERSITY
509 E 3RD STREETBLOOMINGTONIN47401356001673501(C)(3)$150,000$0RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STBOSTONMA02114042697983501(C)(3)$250,000$0RESEARCH
MEMORIAL SLOAN KETTERING CANCER CENTER
PO BOX 27106NEW YORKNY10087131924236501(C)(3)$484,000$0RESEARCH
MILLER SCHOOL OF MEDICINE OF THE UNIVERSITY OF MIAMI
1320 S DIXIE HWY PH 1230CORAL GABLESFL33146590624458501(C)(3)$150,000$0RESEARCH
REGENTS OF THE UNIVERSITY OF MINNESOTA - TWIN CITIES
464-3 MCNAMARA CTR 200 OAK ST SEMINNEAPOLISMN55455416007513501(C)(3)$150,000$0RESEARCH
ST JOSEPH'S HOSPITAL
703 MAIN STPATERSONNJ07503223484247501(C)(3)$10,675$0RESEARCH
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
485 BROADWAY UNIVERSITY HALL THIRDFLOORREDWOOD CITYCA94063941156365501(C)(3)$150,000$0RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
1855 FOLSOM ST SUITE 425SAN FRANCISCOCA94103946036493501(C)(3)$149,933$0RESEARCH
THE UNIVERSITY OF CHICAGO
5801 S ELLIS AVECHICAGOIL60637362177139501(C)(3)$150,000$0RESEARCH
THE UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE RM 405 PARKBUILDINGSALT LAKE CITYUT84112876000525501(C)(3)$150,000$0RESEARCH
UNIVERSITY OF CALIFORNIA LOS ANGELES
405 HILGARD AVENUELOS ANGELESCA900957089956006143501(C)(3)$10,675$0RESEARCH
UNIVERSITY OF MICHIGAN
1000 VICTORS WAY SUITE 1AANN ARBORMI481082744386006309501(C)(3)$10,675$0RESEARCH
UNIVERSITY OF PITTSBURGH
ATTN XXX-XX-XXXX ROSS STREETPITTSBURGHPA15260250965591501(C)(3)$150,000$0RESEARCH
UNIVERSITY OF SOUTHERN CALIFORNIA
UNIVERSITY PARK CAMPUS 3551TROUSDALE PARKWAY STE 160LOS ANGELESCA90089951642394501(C)(3)$10,675$0RESEARCH
UNIVERSITY OF TEXAS
MD ANDERSON CANCER CENTER 1515HOLCOMBE BOULEVARDHOUSTONTX770307009746001118501(C)(3)$300,000$0RESEARCH
UNIVERSITY OF WASHINGTON
1410 NE CAMPUS PARKWAYSEATTLEWA98195916001537501(C)(3)$10,675$0RESEARCH
VANDERBILT UNIVERSITY MEDICAL CENTER
PO BOX 121236DALLASTX75312352528741501(C)(3)$315,000$0RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org19Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationAPPLICATIONS TO LCRF'S SCIENTIFIC GRANT PROGRAM ARE REVIEWED VIA A THREE-PART PROCESS. THEY ARE FIRST SCREENED BY LCRF STAFF TO ENSURE COMPLETENESS AND COMPLIANCE WITH ELIGIBILITY CRITERIA, BUDGET, AND OTHER SUBMISSION REQUIREMENTS. THE APPLICATIONS ARE NEXT SCREENED FOR SCIENTIFIC RATIONALE, CREATIVITY, APPROPRIATENESS OF TIMELINES AND BUDGET, INSTITUTIONAL LETTERS OF SUPPORT AND IMPACT ON THE FIELD OF LUNG CANCER RESEARCH BY THE LCRF SCIENTIFIC ADVISORY BOARD (SAB). NEXT, A SET OF SEMI-FINALISTS ARE INDEPENDENTLY AND COMPREHENSIVELY REVIEWED BY SUBCOMMITTEES OF THREE EXPERTS FROM THE SAB AND SCORED BY STANDARD NIH/NCI CRITERIA. UPON COMPLETION OF THE REVIEW PROCESS, APPLICATIONS ARE RANKED IN ORDER FROM HIGHEST TO LOWEST-SCORING, AND PROPOSALS SELECTED TO BE CONSIDERED FOR FUNDING ARE CHOSEN BASED STRICTLY ON THE APPLICATION SCORES - NO EXTERNAL REVIEW IS ALLOWED. CURRENTLY FUNDED PROJECTS ARE EVALUATED ON AN ANNUAL BASIS WITH AN ASSESSMENT OF A PROGRESS REPORT.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (4 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
DENNIS CHILLEMI
EXECUTIVE DIRECTOR$240,000$0$0$0$0$0$8,492$0$507$0$248,999$0$0$0
AUBREY RHODES
SENIOR VP, STRATEGY$166,072$0$0$0$0$0$6,643$0$11,838$0$184,553$0$0$0
SHEILA SULLIVAN
SR. DIRECTOR, MARKETING & COMMUNICAT$132,600$0$0$0$0$0$5,304$0$29,337$0$167,241$0$0$0
STACEY BOWERS
SR. DIRECTOR, COMMUNITY ENGAGEMENT$119,615$0$0$0$0$0$4,785$0$35,134$0$159,534$0$0$0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS:RESEARCH: DESPITE BEING THE LEADING CAUSE OF CANCER MORTALITY, LUNG CANCER RECEIVES FAR LESS RESEARCH FUNDING PER DEATH. LUNG CANCER RECEIVES $3,580 PER DEATH COMPARED TO BREAST CANCER AT $19,050, PROSTATE CANCER AT $8,116, AND PANCREATIC CANCER AT $4,796. THAT IS WHY FUNDING FROM NON-GOVERNMENTAL ORGANIZATIONS IS SO CRITICAL. THE LUNG CANCER RESEARCH FOUNDATION (LCRF) PLAYS A PIVOTAL ROLE IN THIS FUNDING LANDSCAPE, SUPPORTING EARLY-CAREER INVESTIGATORS WHO, IF NOT FOR OUR FUNDING, MAY NOT RECEIVE FUNDING AT ALL. SINCE 2005, THE LUNG CANCER RESEARCH FOUNDATION, AND ITS PROGENITOR ORGANIZATIONS, HAS BEEN COMMITTED TO FUNDING CUTTING EDGE RESEARCH THAT TRANSFORMS THE LUNG CANCER TREATMENT LANDSCAPE. WHEN WE FIRST OPENED OUR DOORS, OUR MISSION WAS SIMPLE: PROVIDE HOPE BY FUNDING THE BEST RESEARCH AND HELP BRING IT TO PEOPLE. WE HAVE BEEN WILDLY SUCCESSFUL. IN 17 YEARS, WE HAVE BECOME ONE OF THE LARGEST PRIVATE FUNDERS OF LUNG CANCER RESEARCH ENABLING EARLIER DETECTION, DEEPER UNDERSTANDING OF THE MECHANISMS THAT ALLOW LUNG CANCER TO FORM, AND NEW AND EXPANDED TREATMENT OPTIONS THAT HAVE SAVED MANY LIVES. SIMULTANEOUSLY, OUR SCIENTIFIC ADVISORY BOARD HAS BECOME ONE OF THE PREEMINENT BODIES IN THE LUNG CANCER RESEARCH COMMUNITY. FURTHERMORE, OUR INVESTMENT IN EARLY CAREER INVESTIGATORS CONTINUES TO ALLOW NEW TALENT TO THRIVE AND GROW IN THE SPACE AS IS DEMONSTRATED THROUGH FOLLOW-ON FUNDING MANY HAVE RECEIVED SINCE RECEIVING THEIR LCRF GRANT. TO DATE, LCRF HAS PROVIDED 444 RESEARCH GRANTS TOTALING NEARLY $45 MILLION, THE LARGEST AMOUNT PROVIDED BY A NON-GOVERNMENTAL ORGANIZATION DEDICATED TO FUNDING LUNG CANCER RESEARCH. THE SUPPORT WITHIN THE PATIENT COMMUNITY, RESEARCHERS, STRATEGIC PARTNERS, AND INDUSTRY PARTNERS IS KEY TO OUR PRESENT SUCCESSES AS WELL AS ACHIEVING OUR FUTURE VISION TO FIND AN EVENTUAL CURE FOR LUNG CANCER. DURING 2022, WE FUNDED FIFTEEN (15) RESEARCH GRANTS ACROSS FIVE (5) RESEARCH GRANT TRACKS. TWO (2) RESEARCH GRANTS WERE FUNDED THROUGH THE LCRF PILOT GRANT PROGRAM WHICH FUNDS INNOVATIVE PROJECTS ACROSS THE FULL SPECTRUM OF BASIC, TRANSLATIONAL, CLINICAL, EPIDEMIOLOGICAL, HEALTH SERVICES, AND RESEARCH FOCUSED ON A MYRIAD OF TOPICS. THE PROJECTS WILL EXPLORE THE FOLLOWING: A HUMAN PLURIPOTENT STEM CELL-BASED APPROACH TO METASTASIS OF SMALL CELL LUNG CANCER HARNESSING DLL3 AS A CAR T TARGET IN SMALL CELL LUNG CANCER TWO (2) RESEARCH GRANTS WERE FUNDED THROUGH THE LCRF MINORITY CAREER DEVELOPMENT AWARD (CDA). MINORITY APPLICANTS ARE LESS LIKELY TO RECEIVE GRANTS, TO HAVE THE R PHASES OF K01 OR K99 AWARDS ACTIVATED, NEED MORE SUBMISSIONS TO OBTAIN FUNDING, AND OFTEN WILL NOT RESUBMIT PROPOSALS. AS MINORITY APPLICANTS MUST OVERCOME SYSTEMIC AND STRUCTURAL BARRIERS DUE TO RACE, ETHNICITY, COUNTRY OF ORIGIN, SOCIOECONOMIC STATUS, AND/OR LANGUAGE, MANY LEAVE ACADEMIA WHICH FURTHER EXACERBATES THE LACK OF DIVERSITY IN SCIENCE, TECHNOLOGY, ENGINEERING AND MATHEMATICS (STEM) AND MEDICAL FIELDS. TO PROVIDE PROTECTED TIME AND MENTORING TO THESE TRAINEES, WE CONTINUE TO OFFER THE LCRF MINORITY CAREER DEVELOPMENT AWARD (CDA) FOR LUNG CANCER FOR MINORITY POSTDOCTORAL/CLINICAL FELLOWS AND ASSISTANT PROFESSORS WITHIN 10 YEARS OF COMPLETING THEIR MD AND/OR PHD DEGREES TO SUBMIT PROPOSALS. THE PROJECTS WILL EXPLORE THE FOLLOWING: DISCOVERING GENETIC FACTORS OF MET EXON SKIPPING AND DRUG RESISTANCE IN LUNG CANCER TARGETING SMARCA4-DEFICIENT LUNG CANCERS TWO (2) RESEARCH GRANTS WERE FUNDED THROUGH THE LCRF RESEARCH GRANT ON EARLY DETECTION AND PRE-NEOPLASIA IN LUNG CANCER. GIVEN THE SIGNIFICANCE AND NEED FOR EARLY DETECTION OF LUNG CANCER AND ADVANCEMENTS IN MOLECULAR SCREENING, LCRF CONTINUES TO OFFER A FUNDING MECHANISM TO SUPPORT RESEARCH PROJECTS THAT FACILITATE OR ADVANCE THE UNDERSTANDING AND CHARACTERIZATION OF PRE-NEOPLASIA OR APPROACHES FOR EARLY DETECTION OF LUNG CANCER. WORK SUPPORTED THROUGH THIS MECHANISM ADDRESSES IMPORTANT QUESTIONS IN NON-SMALL CELL AND SMALL CELL LUNG CANCER. THE PROJECTS WILL EXPLORE THE FOLLOWING: NONINVASIVE PREDICTION OF LOCAL RECURRENCE IN LOCALIZED NSCLCS AFTER CRT 24-HOUR URINE BASED CTDNA ANALYSIS FOR EARLY STAGE NSCLC DETECTION NINE (9) RESEARCH GRANTS WERE FUNDED THROUGH THE LCRFALK POSITIVE RESEARCH GRANT, LCRF AND MET CRUSADERS RESEARCH GRANT ON MET-DRIVEN LUNG CANCER, LCRF AND EGFR RESISTERS RESEARCH GRANT ON EGFR-DRIVEN LUNG CANCER, LCRF AND KRAS KICKERS RESEARCH GRANT ON KRAS-DRIVEN LUNG CANCER. IN PARTNERSHIP TO VARIOUS PATIENT ADVOCACY GROUPS, LCRF HAS LAUNCHED A NEW FUNDING MECHANISM TO SUPPORT RESEARCH PROJECTS WITH A FOCUS ON CHARACTERIZING, IDENTIFYING, TREATING OR OVERCOMING/PREVENTING RESISTANCE TO THERAPIES IN TUMORS HARBORING ALTERATIONS IN ONCOGENIC DRIVERS IN NSCLC CELLS, TISSUES, MOUSE MODELS, OR PATIENTS. THE PROJECTS WILL EXPLORE THE FOLLOWING: METABOLIC REPROGRAMMING AS A DRIVER OF RESISTANCE IN ALK+ LUNG CANCER IDENTIFYING EPIGENOMIC MECHANISMS OF ALK TKI RESISTANCE TARGETING GLYCOLYSIS IN MET ALTERED LUNG CANCER BRAIN METASTASES EXPLORING NOVEL THERAPEUTIC OPTIONS TO TARGET MET-DRIVEN LUNG CANCERS OPTIMIZATION OF MET-CAR-T/NK CELL-BASED THERAPIES FOR MET EXON 14 SKIPPING NSCLC DRUGGING THE S100A9-RETINOIC ACID PATHWAY: COMPANION BIOMARKER AND THERAPY PREDICTIVE BIOMARKERS AND NEW THERAPEUTIC STRATEGIES TO PREVENT EGFR TKI-REFRACTORY LUNG CANCER PROGRESSION ENHANCING THE PRECISION OF TARGETED THERAPIES FOR EGFR-MUTANT LUNG CANCER KRAS INHIBITORS FOR THE TREATMENT OF INVASIVE MUCINOUS ADENOCARCINOMA IN ADDITION, THE FOUNDATION IS CURRENTLY ADMINISTRATING RESEARCH PARTNERSHIPS WITH THE LUNG CANCER MUTATION CONSORTIUM. LCRF'S PARTNERSHIP WITH THE LUNG CANCER MUTATION CONSORTIUM (LCMC) DATES BACK TO 2011 COVERING THREE CLINICAL TRIALS. THE LCMC2 CLINICAL TRIAL ENROLLED 1,000 PATIENTS VIA A NETWORK OF FOURTEEN (14) NOTABLE DOMESTIC CLINICAL RESEARCH SITES. THE CLINICAL TRIAL STUDIED THE IMPACT OF SMOKING AND TP53 MUTATIONS IN LUNG ADENOCARCINOMA PATIENTS WITH TARGETABLE MUTATIONS. THE LCMC3 CLINICAL TRIAL BEGAN IN 2017, AND HAS ENROLLED 1,000 PATIENTS VIA A NETWORK OF FIVE (5) DOMESTIC CLINICAL RESEARCH SITES. LCMC3 IS DESIGNED AS A NEOADJUVANT AND ADJUVANT TRIAL OF IMMUNE CHECKPOINT BLOCKADE FOR STAGE IB-IIIA NON-SMALL CELL LUNG CANCER. FINAL REPORTING FROM THIS CLINICAL TRIAL SHOULD BE COMPLETED IN LATE 2024. LAUNCHED IN LATE 2020, LCMC4 IS A STUDY WITH A GOAL OF ENLISTING 1,000 PATIENTS VIA A NETWORK OF 25+ DOMESTIC CLINICAL RESEARCH SITES. THE AIM OF THE CLINICAL TRIAL IS TO DETERMINE THE FEASIBILITY OF COMPREHENSIVE MOLECULAR PROFILING TO DETECT ACTIONABLE ONCOGENIC DRIVERS IN PATIENTS WITH SUSPECTED EARLY-STAGE LUNG CANCERS SCHEDULED TO UNDERGO BIOPSIES TO ESTABLISH THE DIAGNOSIS OF LUNG CANCER. SEVEN (7) GRANTS IN SUPPORT OF THE LCMC4 - LEADER NEOADJUVANT SCREENING TRIAL HAVE BEEN MADE. IN 2022, OUR RESEARCH INVESTMENT WAS FUNDED WITHOUT THE NEED FOR DEFICIT SPENDING, AND WE ARE POISED TO GROW OUR RESEARCH INVESTMENT IN THE COMING YEARS.
FORM 990, PART III LINE 4B, PROGRAM SERVICE ACCOMPLISHMENTS:PATIENT EDUCATION & OUTREACH: THE PATIENT EDUCATION PORTFOLIO INCLUDES PRINT AND DIGITAL EDUCATIONAL RESOURCES (PDF DOWNLOADABLE FORMAT AS WELL AS EASILY ACCESSIBLE WEBSITE CONTENT) THAT ARE PROVIDED AT NO COST. THE OVERALL GOALS OF OUR PATIENT EDUCATION MATERIALS ARE TO HELP PATIENTS AND THEIR FAMILIES BETTER UNDERSTAND LUNG CANCER, LEARN ABOUT TREATMENT OPTIONS, PARTICIPATE IN SHARED DECISION MAKING WITH THEIR CARE TEAM, MAKE DECISIONS ABOUT CLINICAL TRIALS, AND UNDERSTAND THE IMPLICATIONS OF COMPREHENSIVE BIOMARKER TESTING. PATIENTS AND CAREGIVERS NEED INFORMATION AT ALL STEPS IN THE CONTINUUM OF CARE, FROM DIAGNOSIS THROUGH TREATMENT AND BEYOND. THE LUNG CANCER RESEARCH FOUNDATION HAS A PORTFOLIO OF EDUCATIONAL RESOURCES TO HELP PATIENTS AND THEIR FAMILIES BETTER UNDERSTAND LUNG CANCER AND LEARN ABOUT THEIR TREATMENT OPTIONS. HELPING PATIENTS TO UNDERSTAND NEW TREATMENTS AND THE HOPE OFFERED BY THESE TREATMENT ADVANCES ARE KEY OBJECTIVES OF OUR EDUCATIONAL MATERIALS. WE ALSO HAVE MATERIALS DESIGNED TO EDUCATE THE PUBLIC ABOUT THE MAGNITUDE OF LUNG CANCER AS A HEALTH CARE PROBLEM AND WAYS TO IDENTIFY SYMPTOMS OF THE DISEASE. IN 2022, LCRF DISTRIBUTED OVER 204,000 EDUCATIONAL PIECES TO LUNG CANCER PATIENTS, CAREGIVERS, ADVOCATES AND HEALTHCARE PROFESSIONALS ACROSS THE NATION IN BOTH PRINT AND DIGITAL FORMAT. OUR WEBSITE ALSO CONTAINS LINKS TO INFORMATION AND RESOURCES, WHICH RECEIVES ON AVERAGE OF MORE THAN 29,000 PAGEVIEWS ANNUALLY. OUR CONTINUED GOAL IS TO STEADILY INCREASE OUR MATERIALS DISTRIBUTED, PARTICULARLY WITH DIGITAL DOWNLOADS AS THERE HAS BEEN A SURGE IN DEMAND FOR READILY AVAILABLE INFORMATION. THE KEY OBJECTIVES OF THE PORTFOLIO ARE TO: EMPOWER PATIENTS AND CAREGIVERS BY INCREASING THEIR KNOWLEDGE OF LUNG CANCER, BIOMARKER TESTING, CLINICAL TRIALS AND TREATMENT OPTIONS; PROVIDE AN UP-TO-DATE AND CREDIBLE SOURCE OF INFORMATION ON AVAILABLE TREATMENTS, EDUCATE PATIENTS ON WHAT TO EXPECT FROM TREATMENT AND WHAT IS CRITICAL FOR OPTIMAL OUTCOMES; PROVIDE TOOLS TO FACILITATE DISCUSSIONS BETWEEN PATIENTS AND HEALTHCARE PROVIDERS; EDUCATE THE PUBLIC ABOUT THE MAGNITUDE OF LUNG CANCER AS A HEALTH CARE ISSUE, WAYS TO IDENTIFY SYMPTOMS OF THE DISEASE, AND EXPLAIN THE IMPORTANCE OF EARLY DETECTION, TUMOR BIOMARKER TESTING AND CLINICAL TRIAL PARTICIPATION; SHARE PROGRESS AND IMPACT OF RESEARCH (INCLUDING THAT WHICH IS FUNDED BY LCRF), AND EXPLAIN WHY FUNDING RESEARCH IS CRUCIAL FOR THE DEVELOPMENT OF NEW TREATMENTS FOR LUNG CANCER; AND ENSURE THAT THE MATERIALS ARE CULTURALLY APPROPRIATE, AT APPROPRIATE LITERACY LEVELS, AND ACCESSIBLE THROUGH A VARIETY OF DELIVERY METHODS (ONLINE, THROUGH COMMUNITY GROUPS AND COMMUNITY HEALTHCARE PROVIDERS, PATIENT AND CAREGIVER FOCUSED EVENTS, ETC.). THE PATIENT EDUCATION MATERIALS ARE EVIDENCE-BASED AND DEVELOPED IN CONJUNCTION WITH THE EDUCATION AND ENGAGEMENT COMMITTEE, COMPOSED OF ONCOLOGISTS, RESEARCHERS, ONCOLOGY NURSES, SOCIAL WORKERS, AND PATIENTS/CAREGIVERS. THE PATIENT EDUCATIONAL PORTFOLIO IS ALSO CRAFTED WITH ASSISTANCE FROM THE FEEDBACK WE RECEIVE FROM OUR COMMUNITY. OUR MATERIALS ARE RATED ON AVERAGE A 4.6/5 ACCORDING TO THE FEEDBACK COLLECTED FROM INDIVIDUALS WHO DOWNLOAD OR ORDER OUR PRINT MATERIALS ON OUR WEBSITE. SAMPLE FEEDBACK INCLUDES: THANK YOU FOR PROVIDING FREE EDUCATIONAL RESOURCES. I AM A THORACIC NURSE NAVIGATOR AND PROVIDE THESE TO ALL OF MY LUNG CANCER PATIENTS. MY PATIENTS LIKE AND APPRECIATE THEM VERY MUCH. THANK YOU SO MUCH FOR PROVIDING INFORMATION TO PEOPLE TRYING TO NAVIGATE A LUNG CANCER DIAGNOSIS AND ALL THE STRESS RELATED TO THE ENTIRE PROCESS. MY MOTHER WAS RECENTLY DIAGNOSED WITH LUNG CANCER. VERY HEARTBREAKING AND A SURPRISE TO US ALL. HEARD NOTHING BUT GOOD REVIEWS ABOUT LCRF SO I LOOK FORWARD TO LEARNING ABOUT EVERYTHING AND I APPRECIATE WHAT YOU ALL DO. I LOVE THE UPDATED LIVING WITH LUNG CANCER BOOKLET. I READ IT FROM COVER TO COVER AND FEEL THAT IT WAS VERY NICELY DONE. IT IS DEFINITELY VERY COMPREHENSIVE IN THAT IT INCLUDES COPING WITH DIAGNOSIS/TREATMENT, INFORMATION ABOUT OUR NEWER TARGETED AND IMMUNOTHERAPIES, AND TREATMENT SIDE-EFFECT MANAGEMENT. GOOD JOB ON YOUR END! LUNG CANCER SUPPORT LINE: OUR LUNG CANCER SUPPORT LINE IS A TOLL-FREE NUMBER (844)-835-4325, AND IS AVAILABLE TO ANYONE AFFECTED BY LUNG CANCER, PRIMARILY LUNG CANCER PATIENTS AND CAREGIVERS. THE SUPPORT LINE OPERATES MONDAY-FRIDAY 9AM-5PM ET AND IS EQUIPPED WITH EXTENSIVE AND UP-TO-DATE RESOURCE GUIDES FOR COMMON NEEDS AND SERVICES FOR LUNG CANCER PATIENTS SUCH AS FINANCIAL ASSISTANCE, TRANSPORTATION OR LODGING TO/FROM MEDICAL APPOINTMENTS, SUPPORT GROUPS, AND MUCH MORE. LUNG CANCER PATIENTS AND THEIR CAREGIVERS MAY CALL OR EMAIL THE PROGRAM AS OFTEN AS THEY WISH, AND THE SERVICE IS OFFERED FREE OF CHARGE. THE LUNG CANCER SUPPORT LINE HELPS FILL AN UNMET NEED BY PROVIDING PERSONALIZED, ONE-ON-ONE SUPPORT TO CALLERS WHO ARE FACING THE CHALLENGES OF LUNG CANCER. IN 2022, WE HAD OVER 1,000 INQUIRIES COME IN THROUGH THE SUPPORT LINE. OVER HALF OF CALLERS ARE NEWLY DIAGNOSED PATIENTS OR CAREGIVERS OF THOSE WHO ARE RECENTLY DIAGNOSED, PROVING THAT THE SUPPORT LINE PROVIDES A TIMELY SERVICE FOR THOSE SEEKING SUPPORT. MANY SUPPORT LINE INQUIRIES ALSO COME IN FROM HEALTHCARE INSTITUTIONS OR COMMUNITY-BASED INSTITUTIONS LOOKING FOR RESOURCES FOR THEIR PATIENTS. OUR CONTINUED GOAL FOR THE SUPPORT LINE IS TO STRENGTHEN OUR COMMUNICATION WITH THOSE WHO ARE NEWLY DIAGNOSED AND ENGAGED IN OUR EDUCATIONAL PROGRAMS. WE ALSO HOPE TO INCREASE OUR SUPPORT LINE REACH BY 10% OVER THE NEXT YEAR VIA TARGETED OUTREACH AND PROMOTION OF OUR SERVICES. THROUGH THE SUPPORT LINE, WE: PROVIDE A QUALITY SERVICE TO PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS, BY OFFERING SUPPORT IN THEIR AREA OF NEED DURING ONE-ON-ONE INTERACTIONS; EMPOWER PATIENTS AND CAREGIVERS THROUGH CONNECTIONS TO RESOURCES (EDUCATION, ASSISTANCE, AND SUPPORT); ENHANCE PATIENTS AND CAREGIVERS' UNDERSTANDING OF LUNG CANCER; INCREASE NUMBER OF SUPPORT INQUIRIES AND TOTAL NUMBER OF INTERACTIONS BETWEEN LCRF SUPPORT SERVICES STAFF AND PERSON SEEKING SUPPORT; AND INCREASE SUPPORT TO UNDERSERVED POPULATIONS BY DEVELOPING RELEVANT RESOURCE GUIDES THAT ADDRESS THE NEEDS OF SPECIFIC UNDERSERVED POPULATIONS (I.E.: PEOPLE OF COLOR, UNINSURED, LGBTQ+, NON-ENGLISH SPEAKING, CAREGIVERS, YOUNG ADULTS). PATIENT EDUCATION PROGRAMMING (VIRTUAL AND IN-PERSON): BARRIERS TO ACCESSING UP-TO-DATE, EXPERT INFORMATION ON LUNG CANCER RESEARCH ADVANCEMENTS AND TREATMENTS ARE EVIDENT BASED ON STIGMA SURROUNDING LUNG CANCER. OUR PATIENT EDUCATION PROGRAMMING AIMS TO INCREASE THE ACCESSIBILITY OF DISEASE AWARENESS AND INFORMATION TO THE LUNG CANCER COMMUNITY BY CREATING EVENTS WHERE LUNG CANCER RESEARCHERS, CLINICIANS, AND OTHER EXPERTS DISCUSS SCIENTIFIC ADVANCEMENT, IMPORTANT UPDATES IN TREATMENTS, AS WELL AS INFORMATION FOR IMPROVING QUALITY OF LIFE WHILE RECEIVING TREATMENT. LCRF ALSO AIMS TO HOST TOPICS THAT WOULD SPECIFICALLY HELP SUPPORT UNDERSERVED POPULATIONS, SUCH AS PEOPLE OF COLOR, THOSE IN LOW SOCIOECONOMIC GROUPS, RURAL DEMOGRAPHICS, AND SPANISH-SPEAKING POPULATIONS, ALL OF WHICH EXPERIENCE A RANGE OF HEALTH DISPARITIES. ATTENDEES, BOTH VIRTUAL AND IN-PERSON, HAVE THE OPPORTUNITY TO LEARN ABOUT LUNG CANCER, TREATMENT OPTIONS AND ADVANCES IN RESEARCH, CLINICAL TRIALS AND AVAILABLE RESOURCES. THEY CAN POSE QUESTIONS TO LUNG CANCER EXPERTS, SHARE THEIR OWN PERSONAL EXPERIENCE, AND ENGAGE WITH THEIR PEERS, FORGING CONNECTIONS AND SUPPORT. THIS PROGRAM ALLOWS PATIENTS AND THEIR FAMILIES TO BECOME MORE INFORMED ABOUT LUNG CANCER AND THEIR OPTIONS FOR NAVIGATING LIFE WITH THEIR DISEASE. THE LEARNING OBJECTIVES OF OUR EDUCATIONAL PROGRAMS ARE: 1. PROVIDE UP-TO-DATE EDUCATION AND INFORMATION ABOUT LUNG CANCER DIAGNOSIS AND TREATMENT, SO OUR AUDIENCE HAS A RELIABLE SOURCE TO TURN TO FOR ACCURATE AND TIMELY INFORMATION; 2. INFORM ABOUT NEW ADVANCEMENTS IN THE FIELD OF LUNG CANCER RESEARCH AND THE TREATMENT LANDSCAPE; 3. PROVIDE OPPORTUNITY FOR DIALOGUE AND A SENSE OF CONNECTION AND COMMUNITY; 4. HIGHLIGHT RESEARCH ADVANCEMENTS, NEWLY DISCOVERED TREATMENT OPTIONS, BEST PRACTICES AND STANDARDS OF CARE FOR PATIENTS UNDERGOING TREATMENT, AND PSYCHOSOCIAL SUPPORT FOR PATIENTS AND THEIR CAREGIVERS; 5. ENSURE AWARENESS OF AND ACCESS TO IMPORTANT LUNG CANCER RESOURCES AND PROGRAMS OFFERED THROUGH LCRF AND ITS PARTNERS. SINCE ITS INCEPTION IN MARCH 2020, WE'VE HAD OVER 5,000 REGISTRANTS FOR OUR #TOGETHERSEPARATELY VIRTUAL EVENTS WITH AN AVERAGE ATTENDANCE RECORD OF OVER 100 INDIVIDUALS PER WEBINAR. MOST OF THE ATTENDEES IN THIS SERIES ARE LUNG CANCER PATIENTS, SURVIVORS, ADVOCATES, CAREGIVERS, AND COMMUNITY PROVIDERS. OUR GOAL IS TO CONTINUE THE SERIES, WHILE FOCUSING ON THE BIGGEST AREAS OF UNMET NEEDS IN THE LUNG CANCER COMMUNITY.
FORM 990, PART III LINE 4B, PROGRAM SERVICE ACCOMPLISHMENTS, CONTINUED:ADDITIONALLY, SINCE 2022, WE'VE REINTRODUCED OUR IN-PERSON PROGRAMMING WITH THE LAUNCH OF OUR LCRF TOGETHER IN-PERSON EDUCATIONAL PROGRAM SERIES. WE HOSTED OUR FIRST LCRF TOGETHER PROGRAM IN CHICAGO, ILLINOIS ON JUNE 28, 2022. THIS EVENT HAD OVER 50 PEOPLE IN ATTENDANCE, INCLUDING PATIENTS AND CAREGIVERS, THOSE WHO HAVE LOST A LOVED ONE, AS WELL AS HEALTHCARE PROFESSIONALS AND INDUSTRY SPONSORS.
FORM 990, PART VI, SECTION A, LINE 2MARY ANN TIGHE AND AARON M. TIGHE - FAMILY RELATIONSHIP MARY ANN TIGHE AND RAYMOND E. CHALME - BUSINESS RELATIONSHIP
FORM 990, PART VI, SECTION B, LINE 11BA DRAFT OF THE RETURN IS REVIEWED FIRST BY THE EXECUTIVE COMMITTEE AND THEN BY THE BOARD OF DIRECTORS PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CTHE BOARD REVIEWS THE CONFLICT OF INTEREST POLICY ANNUALLY, AND ASKS ALL BOARD MEMBERS AND EMPLOYEES TO DISCLOSE ANY CONFLICTS OR POTENTIAL CONFLICTS. IN ADDITION, ALL CONTRACTS ARE REVIEWED FOR KNOWN OR POTENTIAL CONFLICTS BY THE EXECUTIVE DIRECTOR, SR. DIRECTOR FINANCE & ADMINISTRATION AND THE EXECUTIVE COMMITTEE ON AN ON-GOING BASIS.
FORM 990, PART VI, SECTION B, LINE 15THE EXECUTIVE COMMITTEE OF THE BOARD LOOKS AT COMPENSATION SURVEYS AND ALSO COMPARES SALARIES IN SIMILAR ORGANIZATIONS TO DETERMINE THE REASONABLENESS OF SALARIES FOR KEY EMPLOYEES. THE EXECUTIVE COMMITTEE ALSO CONSIDERS OTHER PERFORMANCE-BASED CRITERIA WHICH INCLUDES A WRITTEN PERFORMANCE APPRAISAL OF THE EXECUTIVE DIRECTOR.
FORM 990, PART VI, SECTION C, LINE 18THE IRS FORM 990 IS AVAILABLE ON THE ORGANIZATION'S WEBSITE AND GUIDESTAR'S WEBSITE. ALL OTHER DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON RECEIPT OF A WRITTEN REQUEST.
FORM 990, PART VI, SECTION C, LINE 19FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. ALL OTHER DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON RECEIPT OF A WRITTEN REQUEST.
FORM 990, PART XI, LINE 9:RETURNED GRANT FUNDS 29,596.